INTRODUCTION
Prostaglandins (PGs) mediate a diverse array of biological processes ranging from inflamma tion and cellular differentiation to shock. Yet, as a class, they contain some of the most potent radioprotective agents known' 4). They were initially examined as potential radioprotectants because of previous studies demonstrating that pretreatment with prostaglandins of the E series reduced injury of the gastric mucosa to chemical and physical insults 5°6). This phenomena, as it relates to the gastric mucosa, has been termed "cytoprotection"5. Its mechanism of action is unknown.
Interestingly, the cytoprotective properties of prostaglandins are influenced by sex factors 6'7'8 . Two studies have shown that pretreatment of rats with DiPGE2 significantly reduced the degree of gastric hemorrhage to a subsequent exposure of ethanol in females, compared to males6°8). In one of the studies, 59% less hemorrhages occurred in females . This has been related both to the 10-fold higher renal concentration of prostaglandin dehydrogenase in male rats6), and to differences in the concentrations of alcohol dehydrogenase8) . Renal PGDH concentration in rats has been shown to be influenced by estradiol concentration9) . Differences between sexes have also been noted in prostaglandin synthesis. For example , the livers of female rats possess a sex specific cytochrome P-450 that produces a novel 17-hydroxylation of PGEs10 Variations in PG metabolism between sexes may be of clinical significance in areas other than reproduction, as illustrated by the fact that the incidence of gastric ulcers is higher in males than females"). In addition, indomethacin, a cyclooxygenase inhibitor , induces gastric tumors in female germ free rats, but not in males?).
Beyond the descriptively limited bounds of cytoprotection which relegated that phenomena to the gastric mucosa; pretreatments with DiPGE2 can induce protection from radiation injury in rats12) and mice 2,3). However, with the exception of two studies 12,11) the majority of the radioprotective work has been conducted on males. One study found that pretreatment with misoprostol, a PGE1 analog, did not modify radiationinduced proctitis in female rats 12) . The other study showed a small radioprotective effect in female mice pretreated with DiPGE2 prior to irradiation with fission neutrons13). Yet, no study has compared the radioprotective effects in both sexes. In light of the influence of sex differences on DiPGE2-induced cytoprotection , a study was conducted to determine if sex factors were also important in DiPGE2-induced radioprotection. As reported below, sex factors did not influence the radioprotective properties of DiPGE2. This raises the possibility that the mechanism(s) for radioprotection differs from that of cytoprotection.
MATERIALS AND METHODS
Mice. CD21F1 male and female mice, 10 to 12 weeks old and weighing about 25 g, were obtained from Charles River Laboratories (Kingston, NY) and housed and cared for as previously described2)
.
Prostaglandins. Prostaglandins were obtained from Biomol Research Laboratories (Phi ladelphia, PA). Mice received either 4, 40, 200, or 400,ug DiPGE2 / kg body wt in a volume of 100 ,al by subcutaneous administration in the nape of the neck, as previously described2). Single treatments of DiPGE2 were administered at 5, 10, 15, 30, 40, 60, 80, or 120 min prior to irradiation or at 15 min postirradiation. Control mice were administered an equal volume of saline 10 min prior to irradiation. Irradiation. Groups of 10 mice each were placed in Plexiglas containers and irradiated in a bilateral cobalt-60 gamma field at a dose rate of 1.0 Gy/min as previously described 14). Animals used in the radiation mortality curves received 7 to 15 Gy. The total numbers of animals irradiated per radiation dose and treatment ranged from 20 to 60 for males and 20 for females. In other radiation experiments, mice received 10 Gy. Survival was monitored on a daily basis, and the number of animals surviving 30 days postirradiation was recorded. The LD50130 and 95% confidence limits were determined from probit curve fitting of the 30-day mortality data were fitted to probit curves15). . That study showed that the optimal times for administration was 5 to 10 min prior to irradiation and that a "window" of protection existed which essentially decayed within 1 hr. In the present experiments , similar effects were observed for female mice in that the optimal time of administration was 10 min prior to irradiation and postirradiation treatments were not protective (data not shown). The degree of protection was dose dependent, as shown in Table 1 . Doses as low as 40,ug DiPGE2/kg body wt were radioprotective for female mice, yet were logistically limited in usefulness by the shorter "window" for protection . A dose of 400,ug/kg was selected for further comparison studies in order to minimize some of the behavioral side effects, observed in previous studies with male mice' 2), while retaining a sufficient duration and degree of radioprotection . Diarrhea was a significant side effect in both males and females receiving DiPGE2 with all doses used , including those as low as 4,ug/kg. Although decrements in locomotor behavior were not quantitated , male and female mice both exhibited detectable decreases in ambulation within min following DiPGE2 administration. All mice recovered from the locomotor inactivity and diarrhea epi sodes, with no visually apparent deficits at 1 day postirradiation. No drug induced lethalities were observed in any of the male of female mice receiving DiPGE2 treatments in this study .
Radiation Mortality Curve. Pretreatment with 400 lug DiPGE2/kg was equally effective in enhancing the survival of male and female mice receiving otherwise lethal doses 10 Gy 60Co y-irradiation ( Figure 1 ). The survival parameters of DiPGE2-treated mice were determined by probit analyses (Figure 1 ) and summarized in Table 2 . Untreated male mice had an LD50/30 of 8.35 Gy compared to 8.46 Gy for the untreated female mice. Pretreatment with 400 ,ug DiPGE2/ kg provided a substantial degree of radioprotection, with a DMF of 1 .45 for the male mice and 1.37 for the female mice. The 95% confidence intervals for these values are provided in Table 2 . All DiPGE2 treated males and females survived radiation treatments up to 9 .5 Gy, an otherwise 100% lethal radiation dose in the absence of adequate DiPGE2 pretreatment . The slopes of the probit lines for the male DiPGE2-treated mice were significantly different from the control mice (p=0.01). The variations in the slopes of the probit analyses for the DiPGE2-treated male and female mice ( Figure 1) were not significantly different. The relative effectiveness of DiPGE2 in female mice compared to male mice determined as the ratio of the DMFs was 1 .04 [0.975, 1.222]. This difference was not significant. categories: cytoprotection, chemoprotection, and radioprotection. Prostaglandin-induced cytop rotection has been observed in diverse gastric injury processes including ethanol' 5,8) acid, base, or thermal treatment 5). They have been used clinically to protect pat ients from gastric injury associated with chronic non-steriodal antiinflammatory agent usage, and. also appear to modify radiation-induced injury in patients with oral mucositis resulting from radiochemotherapy16) Since the mechanisms involved have not been clearly elucidated, overlap between categories may occur, particularly if similar mechanisms of injury are involved. In some instances, cytoprotection and chemoprotection are equivalent processes 5). They jare both induced within similar time frames and require that prostaglandin treatment be initiated prior to injury.
There are however, distinct differences between cytoprotection and radioprotection. Con trary to observations on DiPGE2-induced cytoprotection6°8), DiPGE2-induced radioprotective properties are not influenced by sex factors. Pretreatment with DiPGE2 in the present study provides equal degrees of radioprotection from hemotopoietic death in male and female mice. In contrast, cytoprotection has been previously shown to yield a substantially higher degree of protection to females 6°8). This difference may reflect different end-points for assessment, mechanisms of injury, or species differences. Cytoprotection and radioprotection also differ in the dosage of prostaglandin required to elicit an appropriate response. Cytoprotection can be elicited by lower doses of DiPGE2, 5,ug/kg, compared to 40 to 400 pg/kg necessary for radioprotection. Since radioprotection requires larger doses of DiPGE2 and since sex factors in the present study do not influence radioprotective properties, a more likely interpretation is that the two processes, cytoprotection and radioprotection occur by different mechanisms.
Misoprostol has been reported to protect mice from lethality induced by exposure to radiation or to doxorubicin17 . The time courses for both types of protection are similar; however, the degree of chemoprotection observed following misoprostol pretreatment is greater than the radioprotective response 17 . The similarity between the time courses in that study suggested that a single mechanism may be responsible for chemoprotection and for radioprotection17 . That conclusion, while at first glance opposite from the one derived in this paper, is not really at odds, when comparisons are made of the mechanisms of injury involved in the two types of treatments. Both doxorubicin and radiation treatments injure deoxyribonucleic acid, both are potent suppressors of myelopoiesis, and in the misoprostol study 17 , a common end-point of hematopoietic death is being assessed. However, when comparing cytoprotection of gastric mucosa from ethanol injury with that of radioprotection to hematopoietic stem cells and animal survival, the end-point, though common in "protection", differs substantially. Thus prostaglandin-induced cytoprotection may differ from prostaglandin-induced radioprotection of hematopoietic stem cells, while permitting certain similarities between prostaglandin-induced radioprotection and chemoprotection. Cytoprotection may be a component of the radioprotec tive phenomena, particularly as it applies to radiation-induced gastrointestinal death. Radiop rotection studies with prostaglandins and related compounds demonstrate that more than one protective mechanism is elicited 2,3,18 , albeit, that one might be more important for overall protection than another. Studies of 3H-misonidazole uptake into the bone marrow of DiPGE2 treated mice indicate that tissue hypoxia is an important consequence of treatment18', although other mechanisms must also play roles in radioprotection. It is possible that the role of hypoxia in prostaglandin-induced radioprotection18) might negate the influence of sex factor related modifications on other contributing radioprotective mechanisms. Given that prostaglandins protect both sexes equally, are more potent radioprotective agents than sulfhydryls such as WR-2721, are ubiquitous in mammals, and that their concentrations vary in response to the microenvironment, a better understanding of the mechanisms underlying their radioprotective properties would be beneficial.
In conclusion, cytoprotection, chemoprotection, and radioprotection are distinct processes, like large circles at the angles of a triangle, that may overlap depending on the type of injury and the end-point observed.
